Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.


Biotechnology

Wugen

Wugen's headquarters in St. Louis, MO, United States

Kumar Srinivasan

Keith Vendola

Patrick Valme

Chupei Zhang

Preeta Dasgupta

Matthew Cooper

Laura Simpson PhD

Jonathan Miller

Jan Davidson

Ayman Kabakibi

Research and Development Scientists

Clinical and Regulatory Affairs

Leadership Team

Research and Development

Finance and Operations

Advisory Roles

Wugen

Org chart

Teams